Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01490255

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01490255
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01490255. Randomized; single masking; primary purpose diagnostic. Start 2012-01 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity
Acronym
ROMAN
Intervention (Drug)
Ranolazine
Intervention (Drug)
Amlodipine
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01490255
Content hash
26c5db1fb8b632ffb0cc4e70c9108024f0d8a183df20775971e73f5e3ecccd6a